OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
Michail Kokkorakis, Chrysoula Boutari, Michael A. Hill, et al.
Metabolism (2024) Vol. 154, pp. 155835-155835
Open Access | Times Cited: 67
Michail Kokkorakis, Chrysoula Boutari, Michael A. Hill, et al.
Metabolism (2024) Vol. 154, pp. 155835-155835
Open Access | Times Cited: 67
Showing 51-75 of 67 citing articles:
Investigational new drug approval of DA-1241: what we know about GPR119 targeting for MASH therapy?
Khaled Al-Smadi, Ammar Qureshi, Besher Ashouri, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 9, pp. 877-880
Closed Access
Khaled Al-Smadi, Ammar Qureshi, Besher Ashouri, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 9, pp. 877-880
Closed Access
Vaccinium spp. Berries in the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Update of Preclinical and Clinical Research
Ewelina Książek, Zuzanna Goluch-Koniuszy, Marta Kołodziej
Nutrients (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access
Ewelina Książek, Zuzanna Goluch-Koniuszy, Marta Kołodziej
Nutrients (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access
Puerarin: a hepatoprotective drug from bench to bedside
Yi-Xiang He, Mengnan Liu, Hao Wu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Yi-Xiang He, Mengnan Liu, Hao Wu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access
Thyroid Hormone-Mediated Selective Autophagy and Its Implications in Countering Metabolic Dysfunction-Associated Steatotic Liver Disease
Rohit A. Sinha
Endocrinology and Metabolism (2024) Vol. 39, Iss. 5, pp. 686-692
Open Access
Rohit A. Sinha
Endocrinology and Metabolism (2024) Vol. 39, Iss. 5, pp. 686-692
Open Access
Invited Commentary: Radiology at the Forefront in the Fight against Metabolic Dysfunction–associated Steatotic Liver Disease
Sudhakar K. Venkatesh
Radiographics (2024) Vol. 44, Iss. 11
Closed Access
Sudhakar K. Venkatesh
Radiographics (2024) Vol. 44, Iss. 11
Closed Access
NORAD exacerbates metabolic dysfunction-associated steatotic liver disease development via the miR-511-3p/Rock2 axis and inhibits ubiquitin-mediated degradation of ROCK2
Xu Zhang, Tianxing Chen, Zhenhan Li, et al.
Metabolism (2024), pp. 156111-156111
Closed Access
Xu Zhang, Tianxing Chen, Zhenhan Li, et al.
Metabolism (2024), pp. 156111-156111
Closed Access
Mechanism Study of Xiaoyao San against Nonalcoholic Steatohepatitis-Related Liver Fibrosis Based on a Combined Strategy of Transcriptome Analysis and Network Pharmacology
Di Yan, Xiaoling Zhang, Chengmei Ma, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1128-1128
Open Access
Di Yan, Xiaoling Zhang, Chengmei Ma, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1128-1128
Open Access
A clinical decision support tool for metabolic dysfunction-associated steatohepatitis in real-world clinical settings: a mixed-method implementation research study protocol
Jesse Fishman, Theresa Alexander, Yestle Kim, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 10
Open Access
Jesse Fishman, Theresa Alexander, Yestle Kim, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 10
Open Access
Monitoring the liver as a part of the cardio-renal-metabolic continuum – What is cooking and burning with non-invasive tests and treatment options?
Špela Volčanšek, Andrej Janež, Manfredi Rizzo, et al.
Journal of Diabetes and its Complications (2024), pp. 108875-108875
Closed Access
Špela Volčanšek, Andrej Janež, Manfredi Rizzo, et al.
Journal of Diabetes and its Complications (2024), pp. 108875-108875
Closed Access
PDCD4 deficiency in hepatocytes exacerbates nonalcoholic steatohepatitis through enhanced MHC class II transactivator expression
Kaikai Lu, Lei He, Zizhen Guo, et al.
Metabolism (2024) Vol. 161, pp. 156036-156036
Closed Access
Kaikai Lu, Lei He, Zizhen Guo, et al.
Metabolism (2024) Vol. 161, pp. 156036-156036
Closed Access
Polygoni Cuspidati Rhizoma et Radix extract activates TFEB and alleviates hepatic steatosis by promoting autophagy
Chang Li, Chenyu Li, Yi Wang, et al.
Life Sciences (2024) Vol. 359, pp. 123158-123158
Open Access
Chang Li, Chenyu Li, Yi Wang, et al.
Life Sciences (2024) Vol. 359, pp. 123158-123158
Open Access
Protective Effects of Plum on Liver and Gut Injury in Metabolic Dysfunction-Associated Fatty Liver Disease
Ji-Su Kim, Sun Mee Hong, Do‐Kyun Kim, et al.
Nutrients (2024) Vol. 16, Iss. 21, pp. 3760-3760
Open Access
Ji-Su Kim, Sun Mee Hong, Do‐Kyun Kim, et al.
Nutrients (2024) Vol. 16, Iss. 21, pp. 3760-3760
Open Access
NLRP1 is activated by palmitic acid and induced in human metabolic dysfunction-associated steatohepatitis
Miriam Pinilla, Eulalia Campos Baños, María Antonia Martínez‐Sánchez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Miriam Pinilla, Eulalia Campos Baños, María Antonia Martínez‐Sánchez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of Candidates for MASLD Treatment with Indeterminate Vibration-Controlled Transient Elastography
David Martí‐Aguado, José Miguel Carot Sierra, Aida Villalba-Ortiz, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access
David Martí‐Aguado, José Miguel Carot Sierra, Aida Villalba-Ortiz, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access
Construction and Expression of Fc-FGF21 by Different Expression Systems and Comparison of Their Similarity and Difference with Efruxifermin by In Vitro and In Vivo Studies
Xujia Wang, Meng Qin, Aijuan Jia, et al.
Applied Biochemistry and Biotechnology (2024)
Open Access
Xujia Wang, Meng Qin, Aijuan Jia, et al.
Applied Biochemistry and Biotechnology (2024)
Open Access
Pedalitin could regulate lipid metabolism and attenuate inflammatory factors in a non-alcoholic fatty liver disease cell model
Wanying He, Yaying Yu, Hui He, et al.
Journal of Holistic Integrative Pharmacy (2024) Vol. 5, Iss. 4, pp. 314-322
Open Access
Wanying He, Yaying Yu, Hui He, et al.
Journal of Holistic Integrative Pharmacy (2024) Vol. 5, Iss. 4, pp. 314-322
Open Access
Impact of Short-Term Lipid Overload on Whole-Body Physiology
Umur Keles, Nisan Ece Kalem-Yapar, H Hultén, et al.
Molecular and Cellular Biology (2024), pp. 1-12
Open Access
Umur Keles, Nisan Ece Kalem-Yapar, H Hultén, et al.
Molecular and Cellular Biology (2024), pp. 1-12
Open Access
PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression
Milton Boaheng Antwi, Sander Lefere, Dorien Clarisse, et al.
Metabolism (2024), pp. 156128-156128
Closed Access
Milton Boaheng Antwi, Sander Lefere, Dorien Clarisse, et al.
Metabolism (2024), pp. 156128-156128
Closed Access
